The timing and design of stereotactic radiotherapy approaches as a part of neoadjuvant therapy in pancreatic cancer: Is it time for change? Clinical and Translational Radiation Oncology May 2021;28:124-128
Date
05/01/2021
DOI
10.1016/j.ctro.2021.04.002Scopus ID
2-s2.0-85104326512 (requires institutional sign-in at Scopus site)
6 CitationsAuthor List
Ryckman JM, Reames BN, Klute KA, Hall WA, Baine MJ, Abdel-Wahab M, Lin C
Author
William Adrian Hall MD Professor in the Radiation Oncology department at Medical College of Wisconsin